Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC

Watchlist Manager
Cyclacel Pharmaceuticals Inc Logo
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
Watchlist
Price: 6.365 USD -5.98% Market Closed
Market Cap: 14.3m USD

Intrinsic Value

CYCC doesn't have a meaningful market cap.

The intrinsic value of one CYCC stock under the Base Case scenario is 1 051.909 USD. Compared to the current market price of 6.365 USD, Cyclacel Pharmaceuticals Inc is Undervalued by 99%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CYCC Intrinsic Value
1 051.909 USD
Undervaluation 99%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare CYCC to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CYCC?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cyclacel Pharmaceuticals Inc

Current Assets 4.4m
Cash & Short-Term Investments 4.3m
Other Current Assets 108k
Non-Current Assets 18k
PP&E 18k
Current Liabilities 760k
Accounts Payable 221k
Accrued Liabilities 501k
Other Current Liabilities 38k
Non-Current Liabilities 10k
Other Non-Current Liabilities 10k
Efficiency

Free Cash Flow Analysis
Cyclacel Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cyclacel Pharmaceuticals Inc

Revenue
10k USD
Operating Expenses
-10.4m USD
Operating Income
-10.4m USD
Other Expenses
3.9m USD
Net Income
-6.4m USD
Fundamental Scores

CYCC Profitability Score
Profitability Due Diligence

Cyclacel Pharmaceuticals Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
ROIC is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
29/100
Profitability
Score

Cyclacel Pharmaceuticals Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

CYCC Solvency Score
Solvency Due Diligence

Cyclacel Pharmaceuticals Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
49/100
Solvency
Score

Cyclacel Pharmaceuticals Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CYCC Price Targets Summary
Cyclacel Pharmaceuticals Inc

There are no price targets for CYCC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CYCC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CYCC Insider Trading
Buy and sell transactions by insiders